Executive Overview
Tobacco use remains the single greatest preventable cause of disease, disability, and death in the United States. Despite robust clinical guidelines outlining effective cessation interventions, healthcare delivery systems historically struggle to integrate, operationalize, and—most importantly—sustain evidence-based tobacco treatment programs within routine care workflows.
Addressing this persistent healthcare delivery gap, a multi-method implementation study examining the Community Health Network (CHNw) Nicotine Dependence Program (NDP) in Indiana offers a replicable blueprint for health systems nationwide. Developed through a strategic health systems change partnership with the Indiana Department of Health’s (IDOH) Tobacco Prevention and Cessation Commission, the initiative successfully transitioned a localized pilot into an integrated, system-wide clinical model.
By applying rigorous implementation science frameworks—specifically the Consolidated Framework for Implementation Research (CFIR), the Replicating Effective Programs (REP) framework, and Expert Recommendations for Implementing Change (ERIC)—the evaluation maps how real-world healthcare settings can bridge the chasm between evidence-based design and long-term financial and operational sustainability.
Detailed Chronology: The Four Phases of Implementation
The success of the CHNw Nicotine Dependence Program was not a product of chance, but rather the result of a meticulously sequenced, multi-year implementation strategy. Utilizing the REP framework, researchers categorized the program’s developmental trajectory into four distinct phases spanning nearly a decade: pre-conditions, pre-implementation, implementation, and maintenance and evolution.
Phase 1: Pre-Conditions (2016–2017)
The foundational stage focused heavily on assessing organizational readiness and establishing a compelling business case. During an intensive 18-month window, implementation leaders conducted qualitative interviews and internal audits to evaluate historical tobacco cessation efforts and unearth localized barriers. Crucially, stakeholders leveraged expert consultation from specialized external groups—such as MD Anderson’s Tobacco Treatment Program—to avoid common pitfalls. This phase culminated in securing formal executive sponsorship and designating tobacco treatment as a core network priority.
Phase 2: Pre-Implementation (2017–2019)
Spanning 30 months, this phase centered on structural preparation. A multidisciplinary steering committee was formed, bringing together vice presidents of clinical product lines, information technology (IT) specialists, financial officers, and frontline medical personnel.
- Workflow Engineering: Program builders integrated electronic health record (EHR) referral mechanisms and documentation templates to ensure seamless patient routing without overloading clinicians.
- Workforce Development: Standardized training protocols were established, and specialized staff were prepared to deliver free, high-touch cessation counseling.
Phase 3: Implementation (2020–2022)
Launched officially at the onset of 2020, this 36-year-equivalent phase encountered unprecedented external disruption with the arrival of the COVID-19 pandemic. Originally designed with mandatory in-person initial visits, the program faced immediate geographic and logistical barriers. Demonstrating remarkable organizational agility, leadership pivoted the program model to embrace virtual care pathways. This reactive adaptation permanently expanded the program’s reach, eliminating transportation barriers for patients across urban and rural counties alike while actively driving clinical uptake.
Phase 4: Maintenance and Evolution (2023–Present)
Transitioning into long-term sustainment, current operations focus on continuous quality improvement, data-driven audits, and strategic workforce diversification—such as embedding clinical pharmacists directly into primary care offices. By establishing continuous feedback loops through real-time executive dashboards, CHNw has ensured that the program continues to evolve in response to patient needs while maintaining structural resilience.
Supporting Context & Metrics
The quantitative and qualitative dimensions of the CHNw Nicotine Dependence Program underscore both its clinical potency and its structural viability within a complex Midwestern health system.
Patient Reach and Clinical Efficacy
Between 2019 and 2025, the NDP provided comprehensive care to 4,060 unique individuals—encompassing both patients and healthcare system employees—yielding a cumulative total of over 19,000 clinical encounters. The program delivers a structured, 12-week intervention consisting of eight individualized virtual sessions staffed by multidisciplinary clinicians, including physicians, nurse practitioners, pharmacists, registered nurses, and certified Tobacco Treatment Specialists (TTS).
Clinical outcomes have proven exceptional:
- Patient Program Completion Quit Rate: 56%
- Employee Program Completion Quit Rate: 60%
Clinical Sustainability Assessment Tool (CSAT) Results
To evaluate long-term viability, core program staff completed the validated Clinical Sustainability Assessment Tool, rating various organizational domains on a 1-to-7 scale (where 7 represents maximum sustainability).
- Overall Sustainability Score: 6.1 / 7.0
- Outcomes & Effectiveness: 6.6 / 7.0 (highlighting strong objective proof of patient benefit)
- Engaged Staff & Leadership: 6.5 / 7.0 (reflecting deep cultural alignment and active executive buy-in)
- Organizational Readiness: 5.4 / 7.0 (noting persistent systemic challenges regarding direct reimbursement mechanisms and physical/workforce bandwidth)
Official Statements & Qualitative Insights
Frontline providers, implementation directors, and health system executives emphasize that the program’s longevity stems from an "inside-out" operational philosophy—one that respects the expertise of clinical staff and prioritizes patient-centered cultural values over rigid administrative mandates.
"The network as a whole, we’re not directly billing; we’re not directly recouping a lot of that financial side of it, but they know that this is going to benefit the community. And so, the fact that we’ve gained that kind of support… we know that we’re going to improve health, improve quality of life, and prevent a lot of long-term issues downstream if we target this now."
— NDP Clinical Champion
The integration of EHR systems was cited repeatedly as a critical mechanism to prevent clinician burnout. By shifting the logistical burden of tracking and referrals away from busy primary care physicians and embedding specialized personnel into existing clinics, the health system engineered a frictionless care pathway.
"We did not want to put any onus on already burnt-out clinicians… So, referral in our EMR was one of the ways that we implemented that. Now that we’ve expanded, some of our NDP clinicians are embedded in the offices where they work. For example, within our primary care office, our pharmacists are the clinicians that will be treating."
— Dedicated NDP Staff Member
Future Outlook
The empirical success of the Community Health Network Nicotine Dependence Program challenges the traditional paradigm that clinical interventions must generate immediate, direct fee-for-service revenue to justify their existence within private health networks. By demonstrating that long-term upstream chronic disease prevention aligns with broader organizational missions, CHNw has outlined a viable path forward.
Future directions in implementation science must focus on testing the generalizability of this practice-informed blueprint across diverse healthcare markets. As policymakers and health system executives increasingly grapple with value-based care models, the sequential mapping of ERIC implementation strategies provides a robust, evidence-backed roadmap. Scaled appropriately, this framework promises to transform tobacco treatment from a sporadic clinical afterthought into a permanent, sustainable pillar of routine healthcare delivery nationwide.